ARCA biopharma Announces Third Quarter 2023 Financial Results

Stock Information for ARCA biopharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ARCA biopharma Inc.

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger - INRD, AIRC, MODN, ABIO
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WIRE, ABIO, SWAV, MODN
Kuehn Law Encourages WIRE, ABIO, MODN, and SWAV Investors to Contact Law Firm
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SWAV, AIRC, ABIO, MODN
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq - SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE - MODN), ARCA biopharma, Inc. (Nasdaq - ABIO)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANSS, HRT, CHX, ABIO
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.